Bcg/docetaxel/gemcitabineVarious toxicities and lack of efficacy: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1918卷 / 1期

关键词：

D O I：

10.1007/s40278-022-20559-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：102 / 102

相关论文

共 50 条

[31] Capecitabine/gemcitabineVarious toxicities: 3 case reports
Reactions Weekly, 2020, 1793 (1) : 119 - 119
[32] Bcg-vaccineVarious toxicities and lack of efficacy: 2 case report
Reactions Weekly, 2022, 1903 (1) : 90 - 90
[33] Cisplatin/gemcitabineVarious toxicities: 4 case reports
Reactions Weekly, 2019, 1741 (1) : 83 - 83
[34] Cisplatin/gemcitabineVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1686 (1) : 116 - 116
[35] Cisplatin/gemcitabineVarious toxicities: 4 case reports
Reactions Weekly, 2015, 1570 (1) : 53 - 53
[36] Alisertib/gemcitabineVarious toxicities: 6 case reports
Reactions Weekly, 2022, 1935 (1) : 26 - 26
[37] Capecitabine/gemcitabineVarious toxicities: 4 case reports
Reactions Weekly, 2019, 1766 (1) : 91 - 91
[38] Erlotinib/gemcitabineVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1704 (1) : 153 - 153
[39] Docetaxel/poziotinibVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2023, 1964 (1) : 173 - 173
[40] Epoprostenol/treprostinilVarious toxicities and lack of efficacy: 2 case reports
Reactions Weekly, 2024, 2037 (1) : 171 - 171

← 1 2 3 4 5 →